Identify safety and response biomarkers and investigate mechanism of action for your drug development program with CLIA-certified high-parameter immune profiling
search icon

Biomarkers of response

Identify baseline and early on-treatment biomarkers of response and resistance

branching icon

Timing and dosing

Optimize your timing and dosing strategy at the cellular level by profiling immune activation at critical timepoints

group of hexagons icon

Patient selection

Refine patient selection for future trials by enrolling patients based on their unique immune fingerprint

Get the most out of your clinical samples

Get the most out of your clinical samples

Immune profiling can increase success of Phase 1/2 to Phase 3 transition by offering valuable cellular insights into patient response